Immunosignaturing can detect products from molecular markers in brain cancer.
Saved in:
| Title: | Immunosignaturing can detect products from molecular markers in brain cancer. |
|---|---|
| Authors: | Hughes AK; Biodesign Institute, Center for Innovations in Medicine, Arizona State University, Tempe, Arizona, United States of America., Cichacz Z, Scheck A, Coons SW, Johnston SA, Stafford P |
| Source: | PloS one [PLoS One] 2012; Vol. 7 (7), pp. e40201. Date of Electronic Publication: 2012 Jul 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
